Related references
Note: Only part of the references are listed.Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold
Emmanuel Griessinger et al.
CANCER RESEARCH (2023)
The Molecular Context of Oxidant Stress Response in Cancer Establishes ALDH1A1 as a Critical Target: What This Means for Acute Myeloid Leukemia
Garrett M. Dancik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Inhibiting efferocytosis reverses macrophage-mediated immunosuppression in the leukemia microenvironment
Joselyn Cruz Cruz et al.
Frontiers in Immunology (2023)
M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism
Isabel Weinhauser et al.
SCIENCE ADVANCES (2023)
The immunomodulatory function and antitumor effect of disulfiram: paving the way for novel cancer therapeutics
Sijia Zhang et al.
DISCOVER ONCOLOGY (2023)
Lower RNA expression of ALDH1A1 distinguishes the favorable risk group in acute myeloid leukemia
Garrett M. Dancik et al.
MOLECULAR BIOLOGY REPORTS (2022)
Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF-κB subunit RelA
Anneke D. van Dijk et al.
PROTEOMICS CLINICAL APPLICATIONS (2022)
Disulfiram Transcends ALDH Inhibitory Activity When Targeting Ovarian Cancer Tumor-Initiating Cells
Michael W. Caminear et al.
FRONTIERS IN ONCOLOGY (2022)
Aldehyde Dehydrogenase Enzyme Functions in Acute Leukemia Stem Cells
Garrett M. Dancik et al.
Frontiers in Bioscience - Scholar (2022)
NF-κB: A Druggable Target in Acute Myeloid Leukemia
Barbara Di Francesco et al.
CANCERS (2022)
Acute Myeloid Leukaemia Drives Metabolic Changes in the Bone Marrow Niche
Rebecca S. Maynard et al.
FRONTIERS IN ONCOLOGY (2022)
Understanding ER homeostasis and the UPR to enhance treatment efficacy of acute myeloid leukemia
Martyna Sniegocka et al.
DRUG RESISTANCE UPDATES (2022)
ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression
Cuicui Liu et al.
CANCER RESEARCH (2021)
Activation of ALDH1A1 by omeprazole reduces cell oxidative stress damage
Luis Francisco Calleja et al.
FEBS JOURNAL (2021)
Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin
Laura K. Schmalbrock et al.
BLOOD (2021)
CSF1R Inhibition Combined with GM-CSF Reprograms Macrophages and Disrupts Protumoral Interplays with AML Cells
Tatiana Smirnova et al.
CANCERS (2021)
Disulfiram Improves the Anti-PD-1 Therapy Efficacy by Regulating PD-L1 Expression via Epigenetically Reactivation of IRF7 in Triple Negative Breast Cancer
Xin Zheng et al.
FRONTIERS IN ONCOLOGY (2021)
Reproducible immortalization of erythroblasts from multiple stem cell sources provides approach for sustainable RBC therapeutics
Deborah E. Daniels et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML
C. D. DiNardo et al.
BLOOD (2020)
Dissecting pharmacological effects of chloroquine in cancer treatment: interference with inflammatory signaling pathways
Lokman Varisli et al.
IMMUNOLOGY (2020)
Inflammation and tissue homeostasis: the NF-κB system in physiology and malignant progression
George I. Lambrou et al.
MOLECULAR BIOLOGY REPORTS (2020)
Inhibition of NF-κB Signaling Alters Acute Myelogenous Leukemia Cell Transcriptomics
Hakon Reikvam
CELLS (2020)
Roles of DNA repair enzyme OGG1 in innate immunity and its significance for lung cancer
Spiros Vlahopoulos et al.
PHARMACOLOGY & THERAPEUTICS (2019)
A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma
Jiayi Huang et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Repolarizing heterogeneous leukemia-associated macrophages with more M1 characteristics eliminates their pro-leukemic effects
Xiao Yang et al.
ONCOIMMUNOLOGY (2018)
ALDH1A inhibition sensitizes colon cancer cells to chemotherapy
Z. Kozovska et al.
BMC CANCER (2018)
Enhanced mitochondrial DNA repair of the common disease-associated variant, Ser326Cys, of hOGG1 through small molecule intervention
Beverly A. Baptiste et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia
Nanami Gotoh et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2018)
Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1
Maura Gasparetto et al.
HAEMATOLOGICA (2017)
Differential Functional Roles of ALDH1A1 and ALDH1A3 in Mediating Metastatic Behavior and Therapy Resistance of Human Breast Cancer Cells
Alysha K. Croker et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Maintenance of cellular respiration indicates drug resistance in acute myeloid leukemia
Katharina Henkenius et al.
LEUKEMIA RESEARCH (2017)
Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-kB and Nrf2
Bing Xu et al.
CELL DEATH & DISEASE (2017)
Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1
Maura Gasparetto et al.
HAEMATOLOGICA (2017)
Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode
Spiros A. Vlahopoulos
CANCER BIOLOGY & MEDICINE (2017)
ALDHs in normal and malignant hematopoietic cells: Potential new avenues for treatment of AML and other blood cancers
Maura Gasparetto et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
The NCI Genomic Data Commons as an engine for precision medicine
Mark A. Jensen et al.
BLOOD (2017)
Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working party of EBMT
Jonathan Canaani et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
shinyGEO: a web-based application for analyzing gene expression omnibus datasets
Jasmine Dumas et al.
BIOINFORMATICS (2016)
A 17-gene stemness score for rapid determination of risk in acute leukaemia
Stanley W. K. Ng et al.
NATURE (2016)
Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors
G. Venton et al.
BLOOD CANCER JOURNAL (2016)
Dynamic aberrant NF-κB spurs tumorigenesis: A new model encompassing the microenvironment
Spiros A. Vlahopoulos et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
A Phase IIb Trial Assessing the Addition of Disulfiram to Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer
Hovav Nechushtan et al.
ONCOLOGIST (2015)
Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center
R. B. Walter et al.
LEUKEMIA (2015)
Aldehyde dehydrogenases in acute myeloid leukemia
Clay Smith et al.
BONE MARROW NICHE, STEM CELLS, AND LEUKEMIA: IMPACT OF DRUGS, CHEMICALS, AND THE ENVIRONMENT (2014)
Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells
Hong-Quan Duong et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Level of macroautophagy drives senescent keratinocytes into cell death or neoplastic evasion
E. Deruy et al.
CELL DEATH & DISEASE (2014)
NCBI GEO: archive for functional genomics data sets-update
Tanya Barrett et al.
NUCLEIC ACIDS RESEARCH (2013)
Normal Hematopoietic Stem Cells within the AML Bone Marrow Have a Distinct and Higher ALDH Activity Level than Co-Existing Leukemic Stem Cells
Gerrit J. Schuurhuis et al.
PLOS ONE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Identification and Separation of Normal Hematopoietic Stem Cells and Leukemia Stem Cells from Patients with Acute Myeloid Leukemia
Van T. Hoang et al.
STEM CELL NICHE: METHODS AND PROTOCOLS (2013)
The Proteasome Inhibitor Bortezomib Sensitizes AML with Myelomonocytic Differentiation to TRAIL Mediated Apoptosis
Marianne van Dijk et al.
Cancers (2011)
Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
Charles N. Landen et al.
MOLECULAR CANCER THERAPEUTICS (2010)
A scaling normalization method for differential expression analysis of RNA-seq data
Mark D. Robinson et al.
GENOME BIOLOGY (2010)
Suppression of Heavy Drinking and Alcohol Seeking by a Selective ALDH-2 Inhibitor
Maria P. Arolfo et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2009)
Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML
Zhihong Zeng et al.
BLOOD (2009)
Structure of daidzin, a naturally occurring anti-alcohol-addiction agent, in complex with human mitochondrial aldehyde dehydrogenase
Edward D. Lowe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Erythroid and megakaryocytic transformation
A. Wickrema et al.
ONCOGENE (2007)
Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells
John P. Chute et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
ROCR: visualizing classifier performance in R
T Sing et al.
BIOINFORMATICS (2005)
Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples
DJ Pearce et al.
STEM CELLS (2005)
Effects of aldehyde dehydrogenase-2 genetic polymorphisms on metabolism of structurally different aldehydes in human liver
RS Wang et al.
DRUG METABOLISM AND DISPOSITION (2002)
Share Paper
